We understand the many natural benefits of Kratom. Please visit this page to read the facts behind it, and to see how you can join thousands in showing your support for the tree that is making a big difference in lives around the world.
The FDA has unfairly demonized kratom since 2009, and filled the information pipeline with inaccurate, distorted, and, in some cases, completely false information.
The FDA claims kratom is an opioid with the same opioid effects. That is completely untrue. Kratom's alkaloids are what are known as partial agonists, which means they
do hit the same mu-opioid receptors in the brain as actual opioids, but kratom does not suppress the respiratory system which is the primary cause of overdoses. The pharmacology of kratom's alkaloids is vastly different than opioids.
The FDA claims kratom is highly addictive. That is not accurate. While some may develop a dependency, the gold standard for assessing the addiction liability of any
substance are animal studies. When NIDA saw the inaccurate death data promoted by the FDA, they conducted to independent animal studies to see if kratom had the requisite addiction liability to support a scheduling recommendation to the Drug Enforcement Administration
under the Controlled Substances Act. Both studies concluded there was no significant addiction liability. Of significant interest, both studies also observed the test animals showed a reduction in cravings for the reference drug used in the study, which in
this case was heroin.
That explains why NIDA has now funded nearly $15 million in studies on kratom as a potential non-addictive pain option to opioids.